Mark Schoenebaum


Evercore Comments on Axovant Sciences Ltd (AXON) Following Competitor’s Drug Setback

Axovant Sciences Ltd (NYSE:AXON) shares are falling nearly 12% following the news that Lundbeck’s experimental Alzheimer’s drug Idalopirdine failed in a late-stage study. …

Evercore Comments on Acorda Therapeutics Inc (ACOR) as it Ends Development of Epilepsy Drug

Shares of Acorda Therapeutics Inc (NASDAQ:ACOR) are down nearly 5% in early trading Friday, after the drug maker announced that it will discontinue the development …

Analysts Review Gilead Sciences, Inc. Earnings (GILD)

Analysts are weighing in this afternoon on Gilead Sciences, Inc. (NASDAQ:GILD), after the U.

Here’s What Investors Will Be Looking for in Gilead Sciences, Inc. (GILDׁ) Earnings: Evercore ISI

Gilead Sciences, Inc. (NASDAQ:GILD) is scheduled to report its second-quarter earnings after the bell on Tuesday and investors, first and foremost, will be looking …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts